Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1967 2
1969 1
1973 1
1976 2
1979 2
1981 4
1983 2
1984 3
1985 2
1986 5
1987 5
1988 7
1989 6
1990 9
1991 4
1992 8
1993 16
1994 5
1995 27
1996 21
1997 16
1998 15
1999 14
2000 12
2001 19
2002 17
2003 15
2004 16
2005 14
2006 22
2007 22
2008 23
2009 21
2010 23
2011 25
2012 21
2013 29
2014 32
2015 28
2016 29
2017 36
2018 37
2019 41
2020 38
2021 35
2022 28
2023 27
2024 42
2025 23
2026 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

790 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean nakashima a[Author] (1,048 results)?
Survival outcomes in POD1UM-303/InterAACT-2: a phase 3 study of retifanlimab plus carboplatin-paclitaxel in first-line advanced squamous anal cancer.
Rao S, Samalin-Scalzi E, Evesque L, Ben Abdelghani M, Morano F, Roy A, Dahan L, Tamberi S, Dhadda AS, Zampino MG, Casanova N, Guimbaud R, Lievre A, Maurel J, Zhang P, Munteanu MC, Jones M, de la Fouchardiere C, Takashima A, Fakih M, Spano J. Rao S, et al. Among authors: takashima a. Ann Oncol. 2026 May 5:S0923-7534(26)00176-6. doi: 10.1016/j.annonc.2026.04.016. Online ahead of print. Ann Oncol. 2026. PMID: 42097353
VR-based path integration predicts individual risk of rapid cortical decline: a one-year longitudinal study in cognitively unimpaired adults.
Kawabata K, Shima S, Ohdake R, Bagarinao E, Mizutani Y, Tatebe H, Koike R, Kasai A, Ueda A, Ito M, Hata J, Ishigaki S, Toyama H, Tokuda T, Takashima A, Watanabe H. Kawabata K, et al. Among authors: takashima a. Alzheimers Res Ther. 2026 Apr 20. doi: 10.1186/s13195-026-02056-x. Online ahead of print. Alzheimers Res Ther. 2026. PMID: 42010440 Free article. No abstract available.
ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy-phase II investigator-initiated trial (NCCH2412/MK015).
Fujii H, Hirano H, Kudo T, Tsuchihashi K, Shoji H, Okita N, Hirose T, Takashima A, Yokoyama M, Kawasaki M, Shuda Y, Naito M, Ichikawa K, Sekine K, Sato J, Yamamoto N, Kato K. Fujii H, et al. Among authors: takashima a. ESMO Gastrointest Oncol. 2026 Apr 7;12:100322. doi: 10.1016/j.esmogo.2026.100322. eCollection 2026 Jun. ESMO Gastrointest Oncol. 2026. PMID: 42004625 Free PMC article.
RAS/BRAF wild-type metastatic high-methylated colorectal cancer has gene expression patterns related to MSI-H and BRAF V600E mutant: a translational research.
Wakayama S, Takahashi S, Ouchi K, Sakamoto Y, Denda T, Takashima A, Komatsu Y, Nakamura M, Ohori H, Yamaguchi T, Kobayashi Y, Baba H, Kotake M, Amagai K, Kondo H, Shimada K, Yamada Y, Sato A, Yuki S, Okita A, Komine K, Watanabe M, Morita S, Ishioka C. Wakayama S, et al. Among authors: takashima a. Sci Rep. 2026 Mar 8;16(1):12566. doi: 10.1038/s41598-026-42033-w. Sci Rep. 2026. PMID: 41796183 Free PMC article.
Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
Kawagoe R, Moriwaki T, Yamazaki K, Yukami H, Uetake H, Tsuda M, Suto T, Sugimoto N, Ojima H, Takii Y, Yasui H, Komoda M, Shimada Y, Tsuji A, Yamaguchi T, Sawada R, Shinozaki K, Otsu S, Shigeyasu K, Tsuchihashi K, Tamura T, Shiozawa M, Ueno H, Denda T, Ito T, Takashima A. Kawagoe R, et al. Among authors: takashima a. Int J Clin Oncol. 2026 May;31(5):851-858. doi: 10.1007/s10147-026-02999-z. Epub 2026 Mar 4. Int J Clin Oncol. 2026. PMID: 41779341
790 results